Guy Neev, the company’s CEO, will ring the NASDAQ closing bell of the March 31 trading day, which coincides with the last day of Colon Cancer Awareness Month.
Check-Cap’s system included an ingestible imaging capsule designed for colorectal cancer screening.
“We look forward to commemorating our IPO, and more importantly, colon cancer awareness this week,” Mr. Neev. “Screenings save lives, and Check-Cap is proud to be a part of critical innovation in cancer screening technology occurring around the world.”
More articles on gastroenterology:
18 statistics on gastroenterologist habits & burnout
6 gastroenterologists making headlines – March 27, 2015
Olympus introduces new reprocessing instructions for duodenoscopes
